Uncategorized

Multivitamins May Slow Biological Aging

A recent study suggests that daily multivitamin-mineral supplements could slightly slow the biological aging process in older adults, though the effect size is modest and requires further investigation. As part of the COSMOS trial, researchers analyzed data from 958 participants over two years using advanced “epigenetic clocks”—DNA methylation measures that estimate biological age. The results showed a clear divergence between the two supplements tested. Compared with placebo, those taking a daily multivitamin (Centrum Silver) showed a modest but statistically significant reduction in aging rate on two second-generation clocks: PCGrimAge slowed by 0.113 years per year and PCPhenoAge slowed by 0.214 years per year . A critical interaction effect emerged based on baseline aging speed: the benefit on PCGrimAge was substantially stronger among participants already experiencing accelerated biological aging, with a slowing of 0.236 years per year , compared to -0.013 years in those with normal or decelerated aging. In contrast, cocoa extract supplements containing 500 mg of flavanols showed no statistically significant effect on any of the five epigenetic clocks tested, including the newer DunedinPACE measure. While the findings for multivitamins are promising, these small epigenetic changes need further study to determine whether they translate into meaningful reductions in age-related chronic conditions. Source: https://www.nature.com

hyangiu

Recent Posts

ACS Updates Prostate Cancer Screening Guidance

The American Cancer Society (ACS) concludes that the benefits of PSA-based screening for prostate cancer…

22 hours ago

Proton Pump Inhibitor Use Linked to Dementia Risk in Older Adults

Proton pump inhibitor (PPI) use was modestly associated with incident dementia in older adults (pooled…

2 days ago

Long-Term Outcomes of Invasive vs Conservative Management in Stable Coronary Disease: Consistent Evidence From Extended Follow-Up Trials

Extended follow-up of three major trials consistently shows that an initial invasive strategy does not…

3 days ago

Antidepressants Differ in Efficacy and Acceptability in Long-Term Treatment of Major Depressive Disorder

Escitalopram, duloxetine, and agomelatine achieved higher sustained response rates than fluoxetine, while escitalopram and duloxetine…

3 days ago

Intensive BP Control Reduces Cardiovascular Events After Ischemic Stroke

Targeting a systolic blood pressure (BP) of less than 120 mm Hg lowered the incidence…

6 days ago

No Significant Reduction in Major Cardiovascular Events with Intensive BP Lowering in T2D

In patients with type 2 diabetes (T2D) and high cardiovascular risk, targeting a systolic blood…

6 days ago

This website uses cookies.